Update Transaction - Bristol-Myers Squibb (BMY)

Due to about a 10% decrease in the share price of BMY since the June call was sold, the call was bought back today. This continues my strategy for BMY which has traded between about $19 and $21 for the past few months. I continue to sell $21 calls when BMY nears $21, and buy them back when it nears $19. This allows me the possibility to reap even more income out of BMY, while receiving a hefty dividend.

4/6/2009 -- Bought 100 BMY @ 20.48
4/6/2009 -- Sold To Open 1 BMY April $21 Call @ .34
4/17/2009 -- Covered Call Expired
4/20/2009 -- Sold To Open 1 BMY May $21 Call @ .65
4/29/2009 -- Bought To Close 1 BMY May $21 Call @ .11
5/12/2009 -- Sold To Open 1 BMY June $21 Call @ .55
5/27/2009 -- Bought To Close 1 BMY June $21 Call @ .18


The important purchase metrics are below for insight into possible profit and loss (these all include commissions):
Stock Purchase Cost: $2048.00


Downside Coverage (from current price of $19.50): 1.4%
Possible Max Upside: Unlimited

Annualized Max Upside: N/A